North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...
Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.
The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday, Nov. 26, announced proposed changes in Medicare and Medicaid that would formally recognize obesity as a disease, meaning ...
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...
This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...
Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...
The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...
Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.
Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.
22h
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback